Profil
Kevin N.
Heller worked as Senior Medical Director at AstraZeneca PLC from 2013 to 2015.
He served as VP & Head-Antibody Clinical Development at Incyte Corp.
from 2015 to 2018.
He was Chief Medical Officer at NextCure, Inc. from 2018 to 2020.
He held the position of Executive Vice President-Research & Development at Jasper Therapeutics, Inc. from 2021 to 2022.
Dr. Heller earned a doctorate from George Washington University and completed undergraduate studies at Yale University.
Ehemalige bekannte Positionen von Kevin Heller
| Unternehmen | Position | Ende |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 17.03.2022 |
| NEXTCURE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 04.08.2020 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01.04.2018 |
| ASTRAZENECA PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2015 |
Ausbildung von Kevin Heller
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
















